124 related articles for article (PubMed ID: 34508)
1. Thyrotropin binding to cultured lymphocytes and thyroid cells.
Pekonen F; Weintraub BD
Endocrinology; 1978 Nov; 103(5):1668-77. PubMed ID: 34508
[TBL] [Abstract][Full Text] [Related]
2. Binding of bovine thyrotropin to receptors in rat testis and its interaction with gonadotropins.
Amir SM; Sullivan RC; Ingbar SH
Endocrinology; 1978 Jul; 103(1):101-11. PubMed ID: 217636
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the thyrotropin receptor-adenylate cyclase system in neoplastic human thyroid tissue.
Clark OH; Gerend PL; Goretzki P; Nissenson RA
J Clin Endocrinol Metab; 1983 Jul; 57(1):140-7. PubMed ID: 6304132
[TBL] [Abstract][Full Text] [Related]
4. Relevance of the low and high affinity thyrotropin-binding sites of human thyroid membranes to the stimulation of adenylate cyclase.
Lefort GP; Amr S; Carayon P; Nisula BC
Endocrinology; 1984 Mar; 114(3):1005-11. PubMed ID: 6321134
[TBL] [Abstract][Full Text] [Related]
5. Thyrotropin binding and adenylate cyclase activation in normal and neoplastic human thyroid tissue: lack of effect of thyroglobulin.
Clark OH; Gerend PL; Nissenson RA
J Clin Endocrinol Metab; 1982 Jun; 54(6):1157-63. PubMed ID: 7076796
[TBL] [Abstract][Full Text] [Related]
6. Interaction between thyrotropin (TSH) binding inhibitor immunoglobulins (TBII) and soluble TSH receptors in fat cells.
Kishihara M; Nakao Y; Baba Y; Kobayashi N; Matsukura S; Kuma K; Fujita T
J Clin Endocrinol Metab; 1981 Apr; 52(4):665-70. PubMed ID: 6110672
[TBL] [Abstract][Full Text] [Related]
7. Evidence that partially desialylated variants of human chorionic gonadotropin (hCG) are the factors in crude hCG that inhibit the response to thyrotropin in human thyroid membranes.
Hoermann R; Amir SM; Ingbar SH
Endocrinology; 1988 Sep; 123(3):1535-43. PubMed ID: 3402396
[TBL] [Abstract][Full Text] [Related]
8. Inhibition by certain plant extracts of the binding and adenylate cyclase stimulatory effect of bovine thyrotropin in human thyroid membranes.
Auf'mkolk M; Ingbar JC; Amir SM; Winterhoff H; Sourgens H; Hesch RD; Ingbar SH
Endocrinology; 1984 Aug; 115(2):527-34. PubMed ID: 6745167
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a bioeffective monoclonal antibody against thyrotropin beta-subunit.
Hill BL; Lustbader JW; Erlanger BF
Endocrinology; 1987 Feb; 120(2):574-81. PubMed ID: 2433128
[TBL] [Abstract][Full Text] [Related]
10. Thyroglobulin inhibition of thyrotropin binding to thyroid plasma membrane.
Hashizume K; Fenzi G; DeGroot LJ
J Clin Endocrinol Metab; 1978 Apr; 46(4):679-85. PubMed ID: 225342
[TBL] [Abstract][Full Text] [Related]
11. Comparison of binding of bovine and human thyroid-stimulating hormone to receptor sites on human thyroid membranes.
Kermode JC; Thompson BD; Edmonds CJ
J Endocrinol; 1981 Feb; 88(2):205-17. PubMed ID: 6259266
[TBL] [Abstract][Full Text] [Related]
12. The biological activity of bovine and human thyrotropin is differently affected by trypsin treatment of human thyroid cells: thyroid-stimulating antibody is related to human thyrotropin.
Foti D; Russo D; Costante G; Filetti S
J Clin Endocrinol Metab; 1991 Oct; 73(4):710-6. PubMed ID: 1679761
[TBL] [Abstract][Full Text] [Related]
13. Polyphloretin phosphate, an antagonist of thyrotropin action: evidence for an interaction with the hormone rather than the receptor.
Amir SM; Kasagi K; Corretti M; Blank M; Ingbar SH
Endocrinology; 1985 Sep; 117(3):860-8. PubMed ID: 2990874
[TBL] [Abstract][Full Text] [Related]
14. Evidence for species specificity in the interaction between thyrotropin and thyroid-stimulating immunoglobulin and their receptor in thyroid tissue.
Rapoport B; Takai NA; Filetti S
J Clin Endocrinol Metab; 1982 May; 54(5):1059-62. PubMed ID: 6120950
[TBL] [Abstract][Full Text] [Related]
15. The active principles of plant extracts with antithyrotropic activity: oxidation products of derivatives of 3,4-dihydroxycinnamic acid.
Auf'mkolk M; Amir SM; Kubota K; Ingbar SH
Endocrinology; 1985 May; 116(5):1677-86. PubMed ID: 3987612
[TBL] [Abstract][Full Text] [Related]
16. The carbohydrate moiety of bovine thyrotropin is essential for full bioactivity but not for receptor recognition.
Amir SM; Kubota K; Tramontano D; Ingbar SH; Keutmann HT
Endocrinology; 1987 Jan; 120(1):345-52. PubMed ID: 3023032
[TBL] [Abstract][Full Text] [Related]
17. Receptor-binding activity of highly purified bovine luteinizing hormone and thyrotropin, and their subunits.
Williams JF; Davies TF; Catt KJ; Pierce JG
Endocrinology; 1980 May; 106(5):1353-9. PubMed ID: 6244924
[TBL] [Abstract][Full Text] [Related]
18. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding.
Dallas JS; Cunningham SJ; Patibandla SA; Seetharamaiah GS; Morris JC; Tahara K; Kohn LD; Prabhakar BS
Endocrinology; 1996 Aug; 137(8):3329-39. PubMed ID: 8754759
[TBL] [Abstract][Full Text] [Related]
19. Design of a long-lived thyrotropin antagonist from derivatives of human chorionic gonadotropin.
Hoermann R; Amir SM; Nomura T; Ingbar SH
Endocrinology; 1989 Jan; 124(1):223-32. PubMed ID: 2462487
[TBL] [Abstract][Full Text] [Related]
20. Differences in the metabolic clearance of pituitary and serum thyrotropin (TSH) derived from euthyroid and hypothyroid rats: effects of chemical deglycosylation of pituitary TSH.
Constant RB; Weintraub BD
Endocrinology; 1986 Dec; 119(6):2720-7. PubMed ID: 3780548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
